Try our Advanced Search for more refined results

Analysis

Trump's Hiking Of FDA User Fees Unlikely To Speed Approvals

By Emily Field ( March 16, 2017, 10:23 PM EDT) -- Under the White House's 2018 budget, the fees collected by the U.S. Food and Drug Administration from companies to pay for reviewing drugs and medical devices will more than double, but attorneys say it's up in the air whether this will help achieve the president's goal of speeding up the approval process....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!